聯誠精密(002921.SZ)及控股子公司2021年擬向銀行等金融機構申請綜合授信額度不超4.5億元
格隆匯3月19日丨聯誠精密(002921.SZ)公佈,為滿足公司及控股子公司生產經營和建設發展的需要,公司及控股子公司計劃2021年向銀行等金融機構申請綜合授信額度為不超過人民幣4.5億元(在不超過總授信額度範圍內,最終以各銀行實際核准的信用額度為準),在此額度內由公司及控股子公司根據實際資金需求進行銀行借貸。此次授信額度有效期限為2020年度股東大會審議通過之日起至2021年度股東大會召開之日止,有效期內授信額度可循環使用。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.